Moors & Cabot, Inc. Edwards Lifesciences Corp Call Options Transaction History

Moors & Cabot, Inc.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 08, 2024	BUY	$72.54 - $95.56 $7,254 - $9,556	100 New	100 $9,000
Q2 2023 Aug 09, 2023	SELL	$81.41 - $94.33 $7.32 Million - $8.48 Million	-89,900 Reduced 99.89%	100 $9,000
Q1 2023 May 04, 2023	BUY	$74.26 - $84.51 $6.68 Million - $7.61 Million	90,000 New	90,000 $7.45 Million
Q3 2021 Nov 05, 2021	SELL	$102.91 - $122.75 $51,455 - $61,375	-500 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$78.68 - $90.67 $39,340 - $45,335	500 New	500 $5,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.